Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 9.5
Power Rank trend -> Rising
Industry: Diagnostics & Research
Follow @stockchartsai on TwitterIn the past 20 trading days, ILMN has been trading in a range between $154.96 and $141.39 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
ILMN is trading below resistance at $154.96, about 3% to the upside. There is support at $131.39 -13% to the downside. If it can break above the resistance, it could have some more upside. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Illumina Inc $ILMN entered a Green zone 39 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $186.44, a potential upside of 23.4% from the recent price of 151.09. The stock is trading 3.69% (potential upside) below its 52 week high of $156.66 and 68.35 % (potential downside) above its 52 week low of $89.75 - based on the recent price.
Illumina, Inc offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments.
Interpreting Illumina (ILMN) International Revenue Trends Explore how Illumina's (ILMN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects. Source: Zacks Investment Research Thu, 07 Nov 2024 10:16:22 -0500 Sentiment: Neutral |
Illumina To Webcast Upcoming Investor Conferences SAN DIEGO , Nov. 6, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences: Wolfe Research 2024 Healthcare Conference on November 20, 2024 Fireside chat at 6:20am Pacific Time (9:20am Eastern Time) 7th Annual Evercore HealthCONx Conference on December 3, 2024 Fireside chat at 10:20am Pacific Time (1:20pm Eastern Time) For each conference, the webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after each event and will be available for at least 30 days following. Source: PRNewsWire Wed, 06 Nov 2024 16:05:00 -0500 Sentiment: Neutral |
Illumina: Q3 Confirms Improving Fundamentals Illumina is the leader in the undisputed Next Generation Sequencing market. Grail divestment is behind, enabling a margin expansion and fueling a more robust cash flow generation. The stock was down after hours, as much good news has been priced in the recent rally. Source: Seeking Alpha Tue, 05 Nov 2024 13:12:47 -0500 Sentiment: Positive |
ILMN Q3 Earnings Top, '24 Sales View Down, Stock Dips in Aftermarket Illumina's third- quarter revenues from the consumables business show robust growth, offset by the declining instruments business. Source: Zacks Investment Research Tue, 05 Nov 2024 10:20:24 -0500 Sentiment: Neutral |
Illumina (ILMN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. Source: Zacks Investment Research Mon, 04 Nov 2024 20:31:13 -0500 Sentiment: Positive |
Stock Analyzed Each Night
Easily Upload Track Your Stocks
See Lists of Stocks Starting New Trends
The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.